| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w6514 |
| 来源ID | Working Paper 6514 |
| The Costs and Benefits of Intensive Treatment for Cardiovascular Disease | |
| David Cutler; Mark McClellan; Joseph Newhouse | |
| 发表日期 | 1998-04-01 |
| 出版年 | 1998 |
| 语种 | 英语 |
| 摘要 | This paper examines the causes and consequences of reductions in cardiovascular disease mortality, and in particular heart attack mortality, over the past several decades. Analysis of data from Medicare and review of the clinical literature indicate that a large share of the recent decline in heart attack mortality is a result of new medical interventions and increased use of existing interventions. Much of the mortality improvement appears to be the result of changes in the use of pharmaceuticals such as aspirin and clot-busting (thrombolytic) drugs. Greater use of these and other intensive medical procedures have increased the cost of treating heart attacks but have also lead to health improvements. We estimate that the value of improved health is greater than the increased cost of heart attack care, so that the cost of living for people with a heart attack is falling. We present preliminary evidence that patients in managed care receive nearly similar treatment for heart attacks compared to patients with traditional indemnity insurance, but that managed care insurers pay less for the same treatments than do traditional insurers. |
| URL | https://www.nber.org/papers/w6514 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/564032 |
| 推荐引用方式 GB/T 7714 | David Cutler,Mark McClellan,Joseph Newhouse. The Costs and Benefits of Intensive Treatment for Cardiovascular Disease. 1998. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w6514.pdf（1739KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
